Genomic Health Inc.

Public Company, Headquarters Location
101 Galveston Dr., Redwood City, CA 94063-4734, United States
(650)556-9300, (650)556-1132 fax, http://www.genomichealth.com

Primary SIC: Medical Laboratories, Primary NAICS: Medical Laboratories
Description: Services: Genomic research to develop molecular diagnostics.

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Genomic Health Inc., News and Information

WorldFuture 2010: sustainable futures, strategies, and technologies.(Conference news)
The Futurist; 1/1/2010; 1240 words; ...trends in nanotechnology, hydrogen energy, genomic research, and dozens of other key research...president and CEO, Imagination Engines, Inc. [ILLUSTRATION OMITTED] 2. Find your...education, futures methodologies, and health. The future won't wait. We hope to...

FDA OKs Emergency Use of Assay for the Detection and Differentiation of the 2009 H1N1 Influenza A Virus.
Health & Beauty Close-Up; 12/24/2009; 905 words; ...company, and Affymetrix Inc. have announced that...it directly generates genomic sequence from multiple...Pathwork Diagnostics, Inc., for use in determining...medical, and public health experience of its founders...this story may be sent to health@closeupmedia.com...

Genomic Health Announces Publication of Study of Oncotype DX in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy.
Blood Weekly; 12/24/2009; 1279 words; Genomic Health, Inc. (NASDAQ:GHDX) announced that The Lancet Oncology published positive...clinical utility of Oncotype DX in this patient population (see also Genomic Health). The study published in The Lancet Oncology challenges the current...

GENOMIC HEALTH REPORTS DISPOSITION BY CHIEF MEDICAL OFFICER SHAK (California)
US Fed News Service, Including US State News; 12/23/2009; 299 words; WASHINGTON, Dec. 23 -- Genomic Health Inc. (GHDX), Redwood City, Calif., has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial...

Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics.
Cancer Weekly; 12/22/2009; 907 words; Arrayit Diagnostics, Inc., a majority-owned subsidiary...recognized for its groundbreaking work in genomic and proteomic research. Arrayit...Ovarian Carcinoma, Women's Health, Arrayit Diagnostics Inc. This article was prepared by Cancer...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.